SCHEMBL30848338

SCHEMBL30848338

Cc1cnc(Nc2cnn(C(C)C)c2)nc1-c1cnn([C@H](CC#N)C2CCCC2)c1

nearest known ligand 0.85

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 19/20 0.85
▸ TYK2 P29597 11/20 0.85
▸ JAK1 P23458 8/20 0.85
▸ JAK3 P52333 8/20 0.85
▸ ABL1 P00519 3/20 0.85
▸ STAT3 P40763 2/20 0.85
▸ GSK3B P49841 2/20 0.85
▸ AURKB Q96GD4 2/20 0.85
▸ KDR P35968 1/20 0.85
▸ CCNE1 P24864 1/20 0.73
▸ CDK2 P24941 1/20 0.73
▸ FLT3 P36888 8/20 0.54
▸ DAPK3 O43293 2/20 0.51
▸ PAK4 O96013 2/20 0.51
▸ RET P07949 2/20 0.51
▸ LTK P29376 2/20 0.51
▸ CSNK1A1 P48729 2/20 0.51
▸ CLK2 P49760 2/20 0.51
▸ TNK2 Q07912 2/20 0.51
▸ ROCK1 Q13464 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30848277 0.92 JAK2 (1.00) JAK2TYK2JAK1JAK3ABL1
SCHEMBL2356232 0.89 JAK2 (0.82) JAK2TYK2JAK1JAK3ABL1
SCHEMBL30848148 0.88 JAK2 (0.79) JAK2TYK2JAK1JAK3ABL1
SCHEMBL2358683 0.88 JAK2 (0.79) JAK2TYK2JAK1JAK3ABL1
SCHEMBL30848228 0.87 JAK2 (0.81) JAK2TYK2JAK1JAK3ABL1
SCHEMBL30848314 0.87 JAK2 (0.77) JAK2TYK2JAK1JAK3ABL1
SCHEMBL2356496 0.86 JAK2 (0.77) JAK2TYK2JAK1JAK3ABL1
SCHEMBL30848197 0.86 JAK2 (0.76) JAK2TYK2JAK1JAK3ABL1
SCHEMBL17451332 0.85 CCNE1 (0.78) JAK2TYK2JAK1JAK3ABL1
SCHEMBL30848247 0.85 JAK2 (0.75) JAK2TYK2JAK1JAK3ABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4577535-A1 JAK1/JAK2/TYK2 INHIBITORS FOR TOPICAL TREATMENT OF DERMATOLOGICAL DISEASES Hangzhou Highlightll Pharmaceutical Co., Ltd. (CN) 2025-07-02 — — EP claimed
WO-2024041397-A1 JAK1/JAK2/TYK2 INHIBITORS FOR TOPICAL TREATMENT OF DERMATOLOGICAL DISEASES HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD (CN) 2024-02-29 — — WO claimed
EP-4577535-A1 JAK1/JAK2/TYK2 INHIBITORS FOR TOPICAL TREATMENT OF DERMATOLOGICAL DISEASES Hangzhou Highlightll Pharmaceutical Co., Ltd. (CN) 2025-07-02 — — EP disclosed
WO-2024041397-A1 JAK1/JAK2/TYK2 INHIBITORS FOR TOPICAL TREATMENT OF DERMATOLOGICAL DISEASES HANGZHOU HIGHLIGHTLL PHARMACEUTICAL CO., LTD (CN) 2024-02-29 — — WO disclosed
Send feedback